Literature DB >> 2175598

Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.

K Ishida1, K Takeshige, S Minakami.   

Abstract

Endothelin-1 (ET-1) by itself was not an effective stimulus for inducing the superoxide (O2-) generation of human neutrophils, but it enhanced the O2- generation stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) about 2-fold when the cells had been preincubated with ET-1 for 10 min at 37 degrees C. The concentration at which ET-1 was 50% effective was 1 x 10(-10) M, and the maximal effect was obtained at 1 x 10(-8) M. The enhancement was observed over the range of the effective concentrations of FMLP (10(-8)-10(-6) M). ET-1 did not promote the mobilization of intracellular calcium ions and the enhancing effect of ET-1 did not change when calcium ions were depleted. These findings indicate that ET-1 is a potent modulator of human neutrophils and may thus contribute to the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175598     DOI: 10.1016/s0006-291x(05)80061-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40.

Authors:  A Urakami; S Todo; Y Zhu; S Zhang; M B Jin; N Ishizaki; T Shimamura; E Totsuka; V Subbotin; R Lee; T E Starzl
Journal:  J Am Coll Surg       Date:  1997-10       Impact factor: 6.113

2.  Endothelins mediate neutrophil activation, ProMMP-9 release and endothelial cell detachment.

Authors:  Monica C Toffoli; Bichoy H Gabra; Catarina F P Teixeira; Pierre Sirois; Sonia Jancar
Journal:  Inflammation       Date:  2007-01-13       Impact factor: 4.092

3.  Association of endothelin with lung hemorrhage induced by immune complexes in rats.

Authors:  C F P Teixeira; S Jancar; W T Lima; P D'Orléans-Juste; P Sirois
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

4.  Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.

Authors:  Suresh K Gupta; Amit Saxena; Uma Singh; Dharamvir S Arya
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

5.  Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor.

Authors:  C Zouki; C Baron; A Fournier; J G Filep
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

6.  The effect of endothelin-2 (ET-2) on migration and changes in cytosolic free calcium of neutrophils.

Authors:  J G Elferink; B M de Koster
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

7.  Nitric oxide-generating system as an autocrine mechanism in human polymorphonuclear leucocytes.

Authors:  A Riesco; C Caramelo; G Blum; M Montón; M J Gallego; S Casado; A López Farré
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

8.  Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice.

Authors:  Waldiceu A Verri; Thiago M Cunha; Danilo A Magro; Ana T G Guerrero; Silvio M Vieira; Vanessa Carregaro; Guilherme R Souza; Maria das Graças M O Henriques; Sérgio H Ferreira; Fernando Q Cunha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

9.  Endothelin-1 does not prime polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites.

Authors:  S Kopprasch; A Gatzweiler; M Kohl; H E Schröder
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

10.  Gastric mucosal injury induced by local ischemia-reperfusion in rats. Role of endogenous endothelin-1 and free radical.

Authors:  M Hassan; H Kashimura; K Matsumaru; A Nakahara; R Iwata; T Hayashi; H Muto; N Tanaka; K Goto; H Fukutomi
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.